PRO: Should Patients Taking Sodium-Glucose Co-Transporter 2 Inhibitors Be Dropped From the Elective Surgical Program?

被引：0
|
作者：
Ryz, Sylvia [1 ]
Castellucci, Clara [1 ]
机构：
[1] Med Univ Vienna, Dept Anesthesia Intens Care Med & Pain Med, Div Cardio Thorac & Vasc Anesthesia & Intens Care, Austria 14 Spitalgasse 23, A-1090 Vienna, Austria
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2024年 / 38卷 / 07期
关键词：
D O I：
10.1053/j.jvca.2024.02.012
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1587 / 1589
页数：3
相关论文
共 50 条
  • [41] USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN PREOPERATIVE PREPARATION OF PATIENTS FOR BARIATRIC SURGERY
    Shah, P.
    Shah, S.
    OBESITY SURGERY, 2022, 32 (SUPPL 2) : 586 - 586
  • [42] CAN PATIENTS ON SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS SAFELY RECEIVE A UROLOGIC IMPLANT?
    Prebay, Zachary
    Foss, Halle
    Ebbott, David
    Hyman, Jason
    Li, Michael
    Chung, Paul
    JOURNAL OF UROLOGY, 2023, 209 : E865 - E865
  • [43] Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
    Tatsumi, Tomoaki
    Oshitari, Toshiyuki
    Takatsuna, Yoko
    Ishibashi, Ryoichi
    Koshizaka, Masaya
    Shiko, Yuki
    Baba, Takayuki
    Yokote, Koutaro
    Yamamoto, Shuichi
    LIFE-BASEL, 2022, 12 (05):
  • [44] How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients
    Adnan Zaina
    Nunzia Prencipe
    Elena Golden
    Alessandro Maria Berton
    Eldad Arad
    Ali Abid
    Jeryes Shehadeh
    Sameer Kassem
    Ezio Ghigo
    Endocrine, 2023, 80 : 491 - 499
  • [45] The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes
    Whalen, Karen
    Miller, Shannon
    St Onge, Erin
    CLINICAL THERAPEUTICS, 2015, 37 (06) : 1150 - 1166
  • [46] Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Fractures among Patients with Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 23 - 23
  • [47] Use of sodium-glucose co-transporter 2 inhibitors among US patients with type 2 diabetes
    Rajpathak, S.
    Yu, S.
    Engel, S. S.
    Li, Z.
    Fan, C. -P. S.
    Tang, J.
    Hanna, B.
    Williams, J.
    McNeill, A.
    DIABETOLOGIA, 2015, 58 : S180 - S180
  • [48] Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors
    Herrington, William G.
    Savarese, Gianluigi
    Haynes, Richard
    Marx, Nikolaus
    Mellbin, Linda
    Lund, Lars H.
    Dendale, Paul
    Seferovic, Petar
    Rosano, Giuseppe
    Staplin, Natalie
    Baigent, Colin
    Cosentino, Francesco
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1260 - 1275
  • [49] The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors
    Leon Jimenez, David
    Gomez Huelgas, Ricardo
    Miramontes Gonzalez, Jose Pablo
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (02) : 409 - 409
  • [50] Sodium-glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
    Cice, Gennaro
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : I68 - I71
12345